86 related articles for article (PubMed ID: 2370913)
1. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. V. Alternative method for preparation of serum albumin-methotrexate derivative.
Bures L; Lichý A; Bostík J; Spundová M
Neoplasma; 1990; 37(3):225-31. PubMed ID: 2370913
[TBL] [Abstract][Full Text] [Related]
2. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Bures L; Bostík J; Motycka K; Spundová M; Rehák L
Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
[TBL] [Abstract][Full Text] [Related]
3. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative.
Bostík J; Bures L; Spundová M
Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342
[TBL] [Abstract][Full Text] [Related]
4. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
[TBL] [Abstract][Full Text] [Related]
5. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
Bures L; Motycka K; Bostík J; Slavík K; Jirásek A
Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803
[TBL] [Abstract][Full Text] [Related]
6. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
Motycka K; Slavík K; Dyr JE; Balcarová A; Vodrázka Z
Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of methotrexate-immunoglobulin conjugates.
Ghosh MK; Kildsig DO; Mitra AK
Drug Des Deliv; 1989 Jan; 4(1):13-25. PubMed ID: 2789065
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
Wolff D; Frei E; Hofmeister N; Steiner B; Kleine HD; Junghanss C; Sievert K; Terpe H; Schrenk HH; Freund M; Hartung G
Transplantation; 2006 Aug; 82(4):527-33. PubMed ID: 16926597
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers.
Fitzpatrick JJ; Garnett MC
Anticancer Drug Des; 1995 Jan; 10(1):1-9. PubMed ID: 7695810
[TBL] [Abstract][Full Text] [Related]
10. Organ distribution of fibrinogen-bound methotrexate in mice with Gardner lymphosarcoma.
Slavíková V; Dyr JE; Motycka K; Pristoupilová K; Holý P; Slavík K
Neoplasma; 1987; 34(3):269-76. PubMed ID: 3614463
[TBL] [Abstract][Full Text] [Related]
11. Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma.
Motycka K; Slavík ; kocovská A; Cihar R; Spacek P; Kubín M
Neoplasma; 1977; 24(3):271-6. PubMed ID: 578291
[TBL] [Abstract][Full Text] [Related]
12. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.
Fiehn C; Müller-Ladner U; Gay S; Krienke S; Freudenberg-Konrad S; Funk J; Ho AD; Sinn H; Wunder A
Rheumatology (Oxford); 2004 Sep; 43(9):1097-105. PubMed ID: 15199219
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B.
Warnecke A; Fichtner I; Sass G; Kratz F
Arch Pharm (Weinheim); 2007 Aug; 340(8):389-95. PubMed ID: 17628030
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
16. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
Motycka K; Slavík K; Balcarbová A; Cihar R; Spacek P; Kubín M
Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074
[TBL] [Abstract][Full Text] [Related]
17. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
Li AM; Zhang CX; Fu XP; Zhang ZW; Xue QH; Yan RM; Yi LH
Chin Med J (Engl); 2005 May; 118(10):824-7. PubMed ID: 15989762
[TBL] [Abstract][Full Text] [Related]
18. Distribution and pharmacokinetics of methotrexate in localized chemotherapy of solid Gardner's lymphosarcoma.
Slavíková V; Motycka K; Slavík K; Spacek P; Cihar R; Balcarová A
Neoplasma; 1978; 25(2):211-6. PubMed ID: 580447
[TBL] [Abstract][Full Text] [Related]
19. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
Chu BC; Whiteley JM
J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
[TBL] [Abstract][Full Text] [Related]
20. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
